Putnam Investments’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$3.23M Sell
87,723
-25,226
-22% -$583K ﹤0.01% 613
2023
Q3
$2.29M Buy
112,949
+4,100
+4% +$90.1K ﹤0.01% 687
2023
Q2
$2.23M Sell
108,849
-283
-0.3% -$4.24K ﹤0.01% 714
2023
Q1
$1.65M Buy
109,132
+31,408
+40% +$694K ﹤0.01% 769
2022
Q4
$1.85M Buy
77,724
+2,267
+3% +$65.7K ﹤0.01% 741
2022
Q3
$2.66M Buy
75,457
+2,816
+4% +$120K 0.01% 681
2022
Q2
$2.54M Buy
72,641
+32,459
+81% +$1.15M ﹤0.01% 692
2022
Q1
$1.98M Buy
+40,182
New +$2.23M ﹤0.01% 803
2021
Q2
Sell
-28,737
Closed -$3.56M 840
2021
Q1
$3.56M Hold
28,737
0.01% 578
2020
Q4
$4.06M Buy
+28,737
New +$3.19M 0.01% 528

Other funds holding TWST

Putnam Investments's TWST Position: Q4 2023 in Review

Putnam Investments reduced its Twist Bioscience (TWST) stake by 22% in Q4 2023, selling an estimated $583K and leaving 87,723 shares worth $3.23M. The position accounts for ﹤0.01% of the portfolio, ranked #613.

Putnam Investments first reported a position in TWST in Q4 2020 and has held it in 10 quarters since. The position peaked at $4.06M in Q4 2020. 219 funds tracked by Wall St. Rank hold TWST as of Q4 2023.

  • Putnam Investments held 87,723 shares of Twist Bioscience worth $3.23M as of Q4 2023.
  • Putnam Investments sold 25,226 Twist Bioscience shares in Q4 2023, an estimated $583K.
  • Twist Bioscience made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #613 holding.
  • Putnam Investments first reported a position in Twist Bioscience in Q4 2020 and has held it in 10 quarters since.
  • Putnam Investments's Twist Bioscience position peaked at $4.06M in Q4 2020.
  • 219 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.